SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-192292
Filing Date
2022-07-13
Accepted
2022-07-13 07:05:32
Documents
12
Period of Report
2022-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d335098d8k.htm   iXBRL 8-K 27005
  Complete submission text file 0001193125-22-192292.txt   146066

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20220709.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20220709_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20220709_pre.xml EX-101.PRE 10837
6 EXTRACTED XBRL INSTANCE DOCUMENT d335098d8k_htm.xml XML 3234
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 221080178
SIC: 2836 Biological Products, (No Diagnostic Substances)